Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center

• Published in: The breast journal Vol. 15; no. 1; p. 34
• Main Authors: Lee, M Catherine, Rogers, Kendra, Griffith, Kent, Diehl, Kathleen A, Breslin, Tara M, Cimmino, Vincent M, Chang, Alfred E, Newman, Lisa A, Sabel, Michael S
• Format: Journal Article
• Language: English
• Published: United States 01-01-2009
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms - surgery; Female; Humans; Mastectomy; Mastectomy, Segmental - statistics & numerical data; Middle Aged
• ISSN: 1524-4741
• DOI: 10.1111/j.1524-4741.2008.00668.x

Bias in referral patterns and variations in multi-disciplinary management may impact breast conservation therapy (BCT) rates between hospitals. Retrospective studies of BCT rates are limited by their inability to differentiate indicated mastectomies versus those chosen by the patient. Our prospective breast cancer data base was queried for patients with invasive breast cancer who underwent surgical therapy at the University of Michigan over a 3-year period. Demographics, stage and histology were recorded along with the reason mastectomy was performed, categorized as "by need" (contraindication to BCT) or "by choice." Multivariate analysis was used to identify factors significantly associated with mastectomy by choice. BCT was associated with tumor size, histology and nodal status, but not older age, either by choice or by need. Of the 34% of patients initially felt to be poor candidates for BCT, it was absolutely contraindicated in 44%, while 56% were thought to have a tumor-to-breast size ratio too large for successful BCT. Of this latter group, 80% underwent neo-adjuvant chemotherapy in an attempt to downstage the primary tumor and perform BCT, which was successful in over half the patients. For the patients initially thought to be good candidates for BCT, only 15% chose to undergo mastectomy, while 5% eventually required mastectomy due to failed attempts to achieve negative margins. Overall, the BCT rate was 63%, however without the use of neo-adjuvant chemotherapy, the BCT rate would have been only 53%. At a tertiary referral center, BCT rates are driven more by contraindications than patient choice, and may be heavily skewed towards mastectomy due to referral patterns. In addition to tumor factors such as stage and histology, BCT rate can be dramatically impacted by neo-adjuvant chemotherapy or genetic counseling. Examining BCT rates alone as a measure of quality, therefore, is not an appropriate standard across institutions serving diverse populations.